Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Bisphosphonates in breast cancer.

Mathew A, Brufsky A.

Int J Cancer. 2015 Aug 15;137(4):753-64. doi: 10.1002/ijc.28965. Epub 2014 May 20. Review.

2.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
3.

The role of bisphosphonates in breast and prostate cancers.

Brown JE, Neville-Webbe H, Coleman RE.

Endocr Relat Cancer. 2004 Jun;11(2):207-24. Review.

4.

Bisphosphonates for breast cancer.

Pavlakis N, Stockler M.

Cochrane Database Syst Rev. 2002;(1):CD003474. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003474.

PMID:
11869664
5.

Bisphosphonates for cancer patients: why, how, and when?

Body JJ, Mancini I.

Support Care Cancer. 2002 Jul;10(5):399-407. Epub 2001 Oct 19. Review.

PMID:
12136223
6.

Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer.

Gralow J.

Clin Breast Cancer. 2005 Feb;5 Suppl(2):S54-62. Review.

PMID:
15807925
7.

Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.

Harvey HA.

Semin Oncol. 2004 Dec;31(6 Suppl 12):23-30. Review.

PMID:
15719598
8.

A systematic review of the role of bisphosphonates in metastatic disease.

Ross JR, Saunders Y, Edmonds PM, Patel S, Wonderling D, Normand C, Broadley K.

Health Technol Assess. 2004;8(4):1-176. Review.

9.

[Bisphosphonates and bone metastases].

Lortholary A, Jadaud E, Berthaud P.

Bull Cancer. 1999 Sep;86(9):732-8. Review. French.

10.

Bisphosphonates in breast cancer: antitumor effects.

Aft R.

Clin Adv Hematol Oncol. 2011 Apr;9(4):292-9.

PMID:
21558988
11.

Bisphosphonates and breast carcinoma.

Lipton A.

Cancer. 1997 Oct 15;80(8 Suppl):1668-73. Review.

PMID:
9362434
12.

Bisphosphonates: biological response modifiers in breast cancer.

Paterson AH.

Clin Breast Cancer. 2002 Aug;3(3):206-16; discussion 217-8. Review.

PMID:
12196279
13.

The use of bisphosphonates in patients with breast cancer.

Van Poznak CH.

Cancer Control. 2002 Nov-Dec;9(6):480-9. Review.

PMID:
12514566
14.

The role of bisphosphonates in breast cancer.

Theriault RL.

J Natl Compr Canc Netw. 2003 Apr;1(2):232-41. Review.

PMID:
19768882
15.

Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.

Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S.

Can J Oncol. 1995 Dec;5 Suppl 1:54-7.

PMID:
8853526
16.

The role of bisphosphonates in breast cancer management: review article.

Pickering LM, Mansi JL.

Curr Med Res Opin. 2002;18(5):284-95. Review.

PMID:
12240791
17.

Toward new horizons: the future of bisphosphonate therapy.

Lipton A.

Oncologist. 2004;9 Suppl 4:38-47. Review.

18.

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.

Hillner BE, Ingle JN, Berenson JR, Janjan NA, Albain KS, Lipton A, Yee G, Biermann JS, Chlebowski RT, Pfister DG.

J Clin Oncol. 2000 Mar;18(6):1378-91.

PMID:
10715310
19.

Bisphosphonates: clinical experience.

Coleman RE.

Oncologist. 2004;9 Suppl 4:14-27. Review.

20.

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.

Body JJ, Bartl R, Burckhardt P, Delmas PD, Diel IJ, Fleisch H, Kanis JA, Kyle RA, Mundy GR, Paterson AH, Rubens RD.

J Clin Oncol. 1998 Dec;16(12):3890-9. Review.

PMID:
9850035

Supplemental Content

Support Center